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ABSTRACT
Contrary to the results of direct expression, various
human proteins (ferritin light-chain, epithermal
growth factor, interleukin-2, prepro-ghrelin, deletion
mutants of glutamate decarboxylase and arginine
deiminase, and mini-proinsulin) were all soluble in
Escherichia coli cytoplasm when expressed with the
N-terminus fusion of ferritin heavy-chain (FTN-H).
Through systematic investigations, we have found
that a specific peptide motif within FTN-H has a
high affinity to HSP70 chaperone DnaK, and that
the peptide motif was composed of a hydrophobic
core of three residues (Ile, Phe and Leu) and two
flanking regions enriched with polar residues
(Gly, Gln and Arg). It was also observed that all
the recombinant proteins expressed with the fusion
of FTN-H formed spherical nanoparticles with
diameters of 10–15 nm, as confirmed by the trans-
mission electron microscopy image. The protein
nanoparticles are non-covalently cross-linked
supra-molecules formed by the self-assembly func-
tion of FTN-H. Upon the formation of the supra-
molecule,itssizeislikelytobelimitedbytheassembly
properties of FTN-H, thereby keeping the self-
assembled particles soluble. This study reports on
the dual function of FTN-H for fusion expression
andsolubilityenhancementofheterologousproteins:
(i) high-affinity interaction with DnaK and (ii) forma-
tion of self-assembled supra-molecules with limited
and constant sizes, thereby avoiding the undesir-
able formation of insoluble macro-aggregates of
heterologous proteins.
INTRODUCTION
Ferritin plays a central role in iron storage and in the main-
tenance of intracellular iron balance for the growth and
survival of most organisms (1–3). The functions of ferritin
suggest that it may serve as a cytoprotective protein, minim-
izing oxygen-free radical formation by sequestering intracel-
lular iron (4). Ferritin molecules isolated from vertebrates are
composed of two types of subunits (heavy chain and light
chain), whereas those from plants and bacteria contain only
heavy chains. Mammalian heavy chain and light chain show
 54% sequence identity. In mixed subunit 24mer (hetero-
polymers) with a spherical shell structure, heavy (H) and
light (L) chain subunits have similar conformations of prin-
cipally four a helix bundles (5–8). Four years ago, the Korean
Food and Drug Administration prohibited the commercial
manufacture of animal ferritin (from equine spleen extracts),
which had been used to treat human iron deﬁciency, because
of its probable complication of virus infection. Thereafter,
the production of recombinant human ferritin in Escherichia
coli has been used as a possible substitute for equine ferritin
extracts.
It was reported that contrary to ferritin L-chain (FTN-L),
ferritin H-chain (FTN-H) and H–L hybrid (FTN-H fused at
the N-terminus of FTN-L) are soluble in E.coli cytoplasm,
probably due to their enhanced folding efﬁciency. The recom-
binant ferritin H–L hybrid as well as the H-chain showed the
same iron storage activity as natural copolymers of human
ferritin (9). Various human proteins [epidermal growth factor
(EGF), interleukin-2 (IL-2), prepro-ghrelin (ppGRN), a
deletion mutant of glutamate decarboxylase (GAD512–585), a
deletion mutant of arginine deiminase (ADI132–410) and
minipro-insulin (mp-INS)], forming inclusion bodies upon
direct expression, were all soluble in E.coli cytoplasm when
expressed with the N-terminus fusion of ferritin H-chain. Con-
sidering the structural diversity of the above human proteins
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doi:10.1093/nar/gki692fused to ferritin H-chain, it seems reasonable to assume that
the de novo folding of proteins with ferritin H-chain fusion is
not determined by direct protein–protein interaction between
FTN-H and the target protein, but instead, the assistance of a
global folding enhancer, a molecular chaperone, is much more
important. Misfolding and aggregation of proteins are major
damaging consequencesofstress situations, suchasheatshock
and pathophysiological states (10–12). The central cellular
defense against such damage is a molecular chaperone,
which prevents aggregation, assists in refolding and mediates
the degradation of misfolded proteins (13,14). Chaperones can
cooperate in vitro as part of a functional network, in which
‘holder’ chaperones prevent the aggregation of misfolded pro-
teins, whereas ‘folder’ chaperones actively assist in refolding
(15,16). The Hsp70 chaperone DnaK participates in the fold-
ing of a subset of newly synthesized proteins, prevents protein
aggregation in a denatured condition and refolds misfolded
proteins.
Recently, Vandenbroeck et al. (17) identiﬁed conserved
DnaK-binding sites in the N- and C-terminal halves of
helix B and C of diverse 4-helix-bundle proteins, respectively,
that belong to the superfamily of interferon-g/interleukin-
10-related cytokines. These cytokines belong to a relatively
small group of homodimeric proteins with highly interdigit-
ated interfaces exhibiting the strongly hydrophobic character
of the interior core of a single-chain folded domain. They
proposed that the binding of DnaK may constitute the hall-
mark of a novel conserved regulatory mechanism, in which
HSP70-like chaperones assist in the formation of a hydro-
phobic dimeric ‘folding’ interface. Hidaka et al. (18) also
found that the propeptide of guanylyl cyclase, which activates
peptide II (GCAP-II), an endogenous ligand of guanylyl
cyclase C, has a dual function in the proper folding of a mature
peptide. This means that the N-terminus propeptide of pro-
GCAP-II is critical, not only for disulﬁde-coupled folding but
also for the net stabilization (or dimerization) of pro-GCAP-II.
In this study, diverse recombinant proteins, commonly with
FTN-H fusion, were observed to form stable homopolymeric
supra-molecules without the formation of insoluble protein
aggregates. Seemingly, the supra-molecule size is limited
by assembly properties of FTN-H, thereby keeping the
supra-molecules soluble. The target proteins localized inside
the spherical supra-molecules might have been in a protective
environment against undesirable protein aggregation. We also
identiﬁed a speciﬁc DnaK-binding motif within FTN-H and
demonstrated the efﬁcacy of FTN-H as a potent solubility
enhancer upon heterologous protein expression in E.coli.
MATERIALS AND METHODS
PCR-based site-directed mutagenesis
Site-directed mutagenesis for preparing various mutants of
FTN-H and light chain and glutathione S-transferase (GST)
was performed according to the standard protocols for overlap
PCR (19). PCRs were performed in a ﬁnal volume of 20 ml
with the following reagents: 20 mM Tris–HCl, pH 8.3,
100 pmol of each primer, 200 mM dNTPs, 1.5 mM magnesium
chloride and 2.5 U Taq polymerase (BRL). PCR cycling was
performed as follows: initial denaturation at 94 C for 120 s
andthen20cyclesof94 C(45s),60 C(60s)and72 C(120s).
After the completion of 20 cycles, the reaction mixture was
incubated for 5 min at 72 C. The products were gel puriﬁed
after agarose gel electrophoresis.
Recombinant strains and plasmids
After PCR ampliﬁcation usingappropriate primers,each of the
recombinant genes encoding human ferritin H- and L-chain
(FTN-H and FTN-L) and their mutants, human EGF, human
interleukin-2 (hIL-2), GST::(prepro-ghrelin) and other various
fusionmutants(FTN-H::FTN-L,FTN-H::EGF,FTN-H::hIL-2,
FTN-H::ppGRN, FTN-H::GAD512–585, FTN-H::ADI132–410
and FTN-H::mp-INS) was inserted into the NdeI–HindIII
site of plasmid pET28a (Novagen) to construct expression
vector. Upon the fusion construction above, speciﬁc cleav-
age sequence for thrombin protease was placed between
C-terminus of FTN-H and N-terminus of target protein. After
complete DNA sequencing of all the gel-puriﬁed plasmid
vectors, E.coli strain BL21(DE3) [F
  ompT hsdSB(rB
 mB
 )]
was transformed with the plasmid expression vectors, and
kanamycin-resistant transformants were selected. For the
constitutive co-expression of DnaK chaperone with each of
the recombinant proteins above, E.coli dnaK gene was cloned
into a compatible ampicillin-resistant plasmid pHCE19 (2)
(Bioleaders Inc., Korea) (20). The resulting DnaK expression
vectortransformedthesamebacterialhost,E.coliBL21(DE3),
simultaneouslywiththeexpressionvectorforthetargetrecom-
binant gene. Both ampicillin- and kanamycin-resistant trans-
formants were selected using Luria–Bertani (LB) agar plates
supplemented with ampicillin (100 mg/l) and kanamycin
(100 mg/l).
Gene expression, purification of recombinant proteins
and bioactivity assay
For the shake ﬂask experiments (250 ml Erlenmeyer ﬂasks,
37 C, 200 r.p.m. Shaking Incubator IB-3100, New Power
Eng., Korea), LB media containing 100 mg kanamycin
(or both ampicillin and kanamycin where applicable) per
liter of culture was used. When the culture turbidity
(OD600) reached 0.5, the gene expression was induced with
the addition of isopropyl-b-D-thiogalactopyranoside (IPTG)
(0.5 mM). After further 3–4 h cultivation, the recombinant
cells were harvested by centrifugation (6000 r.p.m. for 5 min)
and the cell pellets were resuspended in 5 ml distilled water.
Cell disruption was done by using Branson Soniﬁer (Branson
UltrasonicsCorp.,Danbury,CT).Thecell-freesupernatantand
insoluble protein aggregates were separated at 13000 r.p.m.
for 10 min. The isolated inclusion bodies, if any, were then
washed twice with 1% Triton X-100. The cell-free supernatant
and the washed inclusion bodies were subject to PAGE ana-
lysis, using 14% Tris-glycine precast gel (Novex, San Diego,
CA). Coomassie-stained protein bands were scanned and
analyzed using a densitometer (Duoscan T1200, Bio-Rad,
Hercules, CA).
The puriﬁcation of recombinant proteins was accomplished
using metal afﬁnity chromatography. The corresponding
recombinant gene was cloned into the pET28a (Novagen)
plasmid vector as mentioned previously, and expressed so
that the soluble recombinant protein was synthesized as a
fusion protein containing N-terminus six histidine residues.
The resulting recombinant fusion protein with polyhistidine
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binant protein was puriﬁed through a Ni
2+ column with
ProBond resin according to the following procedures. The
cell-free supernatant containing 1–2 mg of polyhistidine-
tagged recombinant protein was loaded onto ProBond resin
(Ni
+2) column. Prior to sample loading, the resin was washed
twice with 10 column volumes of binding buffer (50 mM
potassium phosphate, 300 mM KCl and 20 mM imidazole,
pH 7.0). Binding buffer contains 20 mM imidazole to
minimize non-speciﬁc binding of untagged protein contamin-
ants, and binding was carried out in a batch mode at 4 C.
Subsequently, the resin was washed twice with 5–8 ml
Tris–HCl (10 mM Tris, pH 8.0) prior to thrombin digestion
step. Thrombin solution 50 ml( 1U / ml, Amersham, Catalog
no. 27-0846-01) was mixed with Tris buffer 4950 ml, and
the resulting reaction buffer was added to the column. After
overnight thrombin digestion (16 h) at room temperature
(22–25 C), the reaction solution was collected and properly
concentrated using microcon YM-10 (Millipore, Ireland)
before SDS–PAGE analysis.
The enzyme activity of recombinant arginine deiminase
(ADI) was assayed by colorimetric determination of the
enzyme reaction product, citrulline. The reaction mixture
(0.1 M potassium phosphate, pH 6.5, 10 mM L-arginine and
0.1mlenzymesolutioninaﬁnalvolumeof1ml)wasincubated
at 37 C for 5 min, and the amount of citrulline was determined
with diacetyl-monoxime (21). The sample heated to 95 C for
10minandtheopticaldensity(A540nm)wasthendetermined.
The protein concentration was determined using the Protein
AssayKit(Bio-Rad)withBSAasastandard.OneunitofADIis
the amount of enzyme catalyzing 1 mmol of arginine to citrul-
line per min at 37 C under the assay conditions.
Peptide synthesis and in vitro DnaK-binding assay
Organic synthesis and puriﬁcation of two peptides (GRIFLQD
and GRALFQD) were implemented by Peptron, Inc. (Taejon,
Korea). Each peptide was dissolved in Tris buffer (40 mM
Tris–HCl and 0.5 mM ATP, pH 7.8), and the peptide con-
centration in the solution was adjusted to 10 mg/l. An aliquot
of 20 ml of each peptide solution was dropped on PVDF
membrane that was already wetted by methanol, and the blot-
ted PVDF membrane was completely dried. [Through Ponceu
S staining (0.25% Ponceu S in 1% acetic acid solution), we
conﬁrmed that a comparable amount of each peptide or pro-
tein was stably immobilized on the PVDF membrane.] The
dried PVDF membrane was put into skim milk solution and
slowly stirred for 30 min. Subsequently, the PVDF membrane
was transferred into Tris buffer solution (40 mM Tris–HCl
and 0.5 mM ATP, pH 7.8) containing 100 nmol of DnaK
(Stressgen). After 1 h, the membrane was washed twice
with phosphate-buffered saline buffer, followed by immuno-
blotting assay using anti-DnaK Ab (monoclonal IgG, mouse,
Stressgen) and anti-mouse immunoglobulin G–horseradish
peroxidase as primary and secondary antibodies, respectively.
Transmission electron microscopy (TEM)
Unstained samples of a puriﬁed protein solution were prepared
for electron microscopy by air-drying small drops of a sample
solution onto carbon-coated copper electron microscopy
grids. To obtain stained images of protein nanoparticles, the
electron microscopy grids containing air-dried samples were
incubated with a 2% (w/v) aqueous uranyl acetate solution for
10 min at room temperature and washed 3–4 times with dis-
tilled water. Protein nanoparticle images were examined using
the Philips Technai 120 kV electron microscope. Electron
diffraction patterns were recorded from a selected area that
is well occupied with protein nanoparticles in order to obtain
high diffraction intensities. Particle size distributions were
made by measuring 50 protein nanoparticles.
RESULTS
Solubility enhancer vector system using
gene fusion of FTN-H
In a previous study, recombinant human ferritin H-, L-chain,
and H–L hybrid were produced using the T7 expression
system of E.coli (9). Interestingly, the recombinant human
ferritin H-chain (FTN-H) and H–L hybrid were intracellular
soluble and active proteins. However, despite high-sequence
homology with FTN-H, recombinant human ferritin L-chain
(FTN-L) was aggregated into inclusion bodies in E.coli
cytoplasm (9,22). With the expectation that the N-terminus
fusion of FTN-H could be a plausible solution for soluble
recombinant protein synthesis in E.coli, we attempted to het-
erologously express the following proteins, all of which were
produced as inclusion bodies upon direct expression in E.coli:
EGF, hIL-2, human ppGRN, deletion mutants of human GAD
(GAD512–585), Mycoplasma ADI (ADI132–410) and human
mini-proinsulin (mp-INS) (23). Figure 1 shows that the
intracellular solubility of all recombinant fusion proteins
(i.e. FTN-H::EGF, FTN-H::IL-2, FTN-H::ppGRN, FTN-
H::GAD512–585, FTN-H::ADI132–410 and FTN-H::mp-INS)
was signiﬁcantly enhanced. For instance, almost 80% of syn-
thesized FTN-H::ppGRN was soluble in E.coli cytoplasm,
although most ppGRN formed inclusion bodies even by
GST fusion (data not shown). ADI catalyzes the hydrolysis
of arginine into citrulline and ammonia, which have been
reported to inhibit cell proliferation by arresting cells in
the G1 phase and also to demonstrate anti-cancer activity.
As shown in Figures 1 and 2A, we conﬁrmed that  30% of
the expressed fusion protein, FTN-H::ADI132–410, was soluble
in bacterial cytoplasm and biologically active as well, clearly
showing arginine-degrading activity.
For the puriﬁcation of ppGRN, FTN-H::ppGRN in a cell-
free supernatant from whole-cell lysate was loaded to an Ni
+2
column and retained inside the column due to the afﬁnity
interaction between Ni
+2 and the N-terminus polyhistidine
tag of FTN-H::ppGRN. Thrombin was subsequently added
to the column to separate it from ppGRN by cleaving the
fusion construct. As shown in Figure 2B (lane 3), ppGRN
was successfully recovered through thrombin digestion of
the fusion construct, FTN-H::ppGRN. Complete separation
and puriﬁcation of ppGRN was achieved after the removal
of thrombin from the eluted solution. The other target proteins
in the FTN-H fusion constructs were successfully puriﬁed
through the same procedure (data not shown).
Search for putative DnaK-binding motif(s) in FTN-H
When 2-HEDS [2-hydroxyethyl disulﬁde (HOCH2CH2-S-S-
CH2CH2OH), 15 mM] was present in the growth culture of
Nucleic Acids Research, 2005, Vol. 33, No. 12 3753the recombinant E.coli, almost 100% of the recombinant
FTN-H formed insoluble aggregates after gene expression.
However, inthe absenceof2-HEDS,>80%ofthe recombinant
FTN-H was soluble in bacterial cytoplasm (Figure 3A).
2-HEDS is the oxidized form of DTT. When 2-HEDS is pre-
sent in bacterial cytoplasm, its reduction is subject to the
inducement of thiol oxidation of proteins, thereby promoting
the formation of mis-linked disulﬁde bonds and protein aggre-
gation. Comparing the results of reducing and non-reducing
SDS–PAGE analyses, the aggregation of recombinant FTN-H
by 2-HEDS seems to have occurred via intramolecular
mislinkage of disulﬁde bridges (data not shown). From
Figure 3A, even in the presence of 2-HEDS, the solubility
of recombinant FTN-H was signiﬁcantly increased when
the HSP70 molecular chaperone, DnaK, was constitutively
co-expressed. The co-expression of DnaK was carried out
using a constitutive promoter localized in another expression
vector, pHCE19 (2) (Bioleaders Inc., Korea) (20). Thus, it was
possible to maintain the high cytoplasmic concentration of
DnaK before the T7 expression of FTN-H was induced by
IPTG. As shown in Figure 3B, the insoluble nature of recom-
binant FTN-L, however, never changed even with DnaK
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The results shown in Figure 3 suggest that FTN-H must be
capable of having a signiﬁcant interaction with DnaK, pre-
sumably via special amino acid residues acting as high-afﬁnity
motif(s) for DnaK.
DnaK generally recognizes and binds to the hydrophobic
region of the unfolded polypeptide chain. Thus, to identify
the DnaK-binding motif(s), if any, the ﬁve hydrophobic clus-
ters consisting of three amino acids (34VYL36, 81IFL83,
105LHL107, 133FIE35 and 161APE163) within the FTN-H
sequence were ﬁrst considered. They showed a relatively
high hydrophobicity based on their theoretical hydropathy
proﬁle (Figure 4A). Using the site-directed mutagenesis tech-
nique, each of the ﬁve hydrophobic clusters was mutated
one at a time by replacing the hydrophobic amino acids
in each cluster with arginine residue (34VYL36!34RRR36,
81IFL83!81RRR83, 105LHL107!105RHR107, 133FIE135!
133RRE135 and 161APE163!161RRE163), thereby result-
ing in the construction of ﬁve FTN-H-derived mutants. Each
mutant was expressed in the E.coli T7 expression system, and
its intracellular solubility was analyzed. The purpose of
mutating the wild-type sequence was to identify the hydro-
phobic patch that is recognized and bound by DnaK. If a
certain hydrophobic cluster is responsible for DnaK binding,
replacing the hydrophobic amino acids comprising the hydro-
phobic patchwith strongly charged amino acids, such as argin-
ine, will signiﬁcantly affect the solubility of the polypeptide
chain in bacterial cytoplasm. After gene expression, three
(B)
(A)
Figure 4. (A) Theoretical hydropathy profile of FTN-H and five hydrophobic tripeptide-residues to be replaced by arginine residues through site-directed
mutagenesis. (B) E.coli cytoplasmic solubility of recombinant FTN-H mutants that were prepared by replacing the hydrophobic tripeptide residues [illustrated
in (A)] with arginine residues.
Nucleic Acids Research, 2005, Vol. 33, No. 12 3755FTN-H mutants (34RRR36, 81RRR83 and 105RHR107) were
aggregated into inclusion bodies in E.coli cytoplasm
(Figure 4B), implying that the three hydrophobic tripeptides
(34VYL36, 81IFL83 and 105LHL107) could be putative
motifs interacting with DnaK. Although DnaK was con-
stitutively co-expressed with the three mutants (34RRR36,
81RRR83 and 105RHR107) using the same constitutive pro-
moter system, the inclusion body formation of the three FTN-
H mutants was never prevented (Figure 5). This is contrary to
the case of wild-type FTN-H, in which the soluble FTN-H
synthesis was resumed by DnaK co-expression even in the
presence of 2-HEDS (Figure 3A). Therefore, it seems that
there must be a special motif(s) in FTN-H with a high afﬁnity
to DnaK, leading to the syntheses of soluble FTN-H and other
soluble heterologous proteins with FTN-H fusion.
Identification and validation of a specific
DnaK-binding motif
Case of the ferritin-light chain mutant. The alignment of the
amino acid sequences between FTN-H and FTN-L shows that
the sequence of a putative DnaK-binding motif, 81IFL83, is
completely different from the aligned cognate sequence
(77ALF79) of FTN-L (Figure 6A). Through site-directed
mutagenesis, the nucleotide sequence encoding 77ALF79 of
FTN-L was replaced with the sequence coding for 77IFL79
so that FTN-L might have the putative DnaK-binding motif
of FTN-H. The resulting substitution mutant of FTN-L
(77IFL79) was expressed in E.coli. Surprisingly, the results
of SDS–PAGE analysis showed that >50% of the synthesized
FTN-L mutant was soluble in the bacterial cytoplasm
(Figure 6B), whereas almost 100% of wild-type FTN-L was
aggregated into inclusion bodies (Figures 1 and 3). Figure 6C
shows that it is very similar to the case of FTN-H, in which
most of the FTN-L mutant was aggregated by the addition of
2-HEDS, but the synthesis of the soluble FTN-L mutant was
resumed by DnaK co-expression (Figure 6C). Consequently,
it is evident that the tripeptide motif (IFL) from FTN-H played
a critical role in increasing the solubility of the FTN-L mutant,
probably by attracting the DnaK chaperone.
Case of the (GST mutant)::ppGRN. As described earlier in this
study (Figure 1), the GST fusion protein, GST::ppGRN, was
almost 100% aggregated upon expression in E.coli. The fusion
expression of ppGRN was attempted using a GST mutant
containing a DnaK-binding motif from FTN-H. First, several
hydrophobic clusters in the N-terminus region of native GST
were mutated by replacing the hydrophobic amino acids with
arginine residues, and the cytoplasmic solubility of the result-
ing GST mutants was analyzed after their expression in the
same recombinant E.coli system. As a result, a high degree of
aggregation was observed in the synthesis of a GST mutant
(85LAP87!85RRR87)(Figure7A).Thisisverysimilartothe
previous results obtained with FTN-H mutants (Figure 4).
Thus, the hydrophobic cluster (85LAP87) and the sequence
around 85LAP87 seem to be important sites in the interaction
between GST and DnaK. To prepare GST mutants containing
theputativeDnaK-bindingmotif(81IFL83)ofFTN-H,weﬁrst
tried to replace the 85LAP87 of GST with the 81IFL83 of
FTN-H, thereby constructing a substitution mutant of GST,
85LAP87!85IFL87 (GST-m1). We also constructed the fol-
lowing additional mutants of GST containing 80RIFLQ84
and 79GRIFLQD85 of FTN-H: 84LLAPV88!84RIFLQ88
(GST-m2) and 83QLLAPVN89!83GRIFLQD89 (GST-m3).
Then, three fusion proteins of ppGRN (GST-m1::ppGRN,
GST-m2::ppGRN and GST-m3::ppGRN) were synthesized
using the same T7 gene expression system. From the results
of the SDS–PAGE analysis, it is surprising that  50% of the
synthesized GST-m3::ppGRN was in the form of soluble
protein in E.coli cytoplasm (Figure 7B). Figure 7C shows
that almost 100% re-aggregation of GST-m3::ppGRN was
also observed in the presence of 2-HEDS, but that the soluble
GST-m3::ppGRN appeared again after DnaK co-expression,
which is very similar to the cases of FTN-H and the FTN-L
mutant.
Apparently, the two mutants, GST-m3 and FTN-L
(77IFL79), have a common foreign sequence, GRIFLQD,
originating from FTN-H, which is therefore likely to be a
peptide motif with a high afﬁnity to DnaK. It is generally
accepted that DnaK binds to the hydrophobic region in an
almost extended polypeptide chain of unfolded protein at
SSS S S S IS IS IS IS IS IS
34VYL36 → RRR 81IFL83 → RRR 105LHL107 → RHR
FTN-H
Figure 5. Solubilityof three FTN-H mutants in recombinant E.coli cytoplasm, expressed with (represented by solid underlines) and without (represented by dotted
underlines) DnaK co-expression. Arrows indicate co-expressed DnaK band.
3756 Nucleic Acids Research, 2005, Vol. 33, No. 12the initial stage of protein folding. Therefore, the important
factor determining the DnaK binding may not be protein
conformation but the sequence structure of the binding
motif. The sequence, GRIFLQD, consists of hydrophilic
(polar) amino acid residues ﬂanking the hydrophobic tripep-
tide. In the middle of the tripeptide, an amino acid with an
aromatic side chain (Phe) is located (Figure 8). Presumably,
such a unique sequence in the extended polypeptide chain can
be easily recognized by DnaK.
In vitro DnaK-binding assay. Through an in vitro assay
experiment, we investigated the actual binding of DnaK to
the speciﬁc peptide GRIFLQD (named ‘peptide A’) above.
In addition to the peptide A, we prepared another peptide,
(A)
(B)
(C)
Figure 6. (A) Amino acid sequence alignment between FTN-H and FTN-L. (B) Schematic representation and E.coli cytoplasmic solubility of FTN-L (wild) and
FTN-L mutant (77IFL79) containing a putative DnaK-binding motif from FTN-H. (C) Cytoplasmic solubility of recombinant FTN-L mutant in the presence (+)
or absence ( ) of 2-HEDS with (+) or without ( ) DnaK co-expression in the recombinant E.coli culture.
Nucleic Acids Research, 2005, Vol. 33, No. 12 3757GRALFQD (named ‘peptide B’), which exactly corresponds
to the 79th–85th amino acids of FTN-L that were replaced
by peptide A upon the preparation of the FTN-L mutant
(Figure 6B). From the results of Ponceau S staining
(Figure 9A), it seems obvious that both peptides A and B
were well immobilized on the PVDF membrane. The addition
of DnaK to the immobilized peptides and the subsequent
immunoblotting analysis using anti-DnaK monoclonal Ab
showed that DnaK bound only to peptide A (Figure 9A),
which clearly shows that the sequence 83GRILFQD89 within
FTN-H has a high binding afﬁnity for DnaK.
We also implemented an additional in vitro assay of
DnaK binding to FTN-H and the FTN-L mutant containing
GRIFLQD, and to wild type FTN-L that did not contain
GRIFLQD (negative control). Since DnaK binds to an unfol-
ded nascent chain at the early stage of folding, we performed
the overlay assay using puriﬁed and unfolded FTN-H, FTN-L
and FTN-Lmutant.(The puriﬁed proteins were unfolded using
a denaturation buffer containing 1 mM DTT and 8 M urea.)
Evidently, from Figure 9B, DnaK bound to only the proteins
containing GRIFLQD, i.e. FTN-H and the FTN-L mutant,
whereas DnaK binding never happened to wild-type FTN-L.
Through this additional in vitro assay, we conﬁrmed that the
peptide motif GRILFQD (i.e. the 83rd–89th amino acids
of FTN-H) has a high binding afﬁnity to DnaK and seems
to be directly related to the synthesis of soluble heterologous
proteins.
Supra-molecule formation by self-assembly
function of N-terminus FTN-H
From TEM images of the puriﬁed FTN-H-fusion proteins
(Figure 10A), it is very interesting that all the fusion proteins
(B)
(C)
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GST-m3::ppGRN
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Figure 7. (A) Solubility of GST (wild) and GST mutant (85RRR87) in E.coli cytoplasm. (B) Cytoplasmic solubility of recombinant fusion proteins of ppGRN,
prepared through N-terminus fusion of GST (wild) and three GST mutants (GST1-GST3) derived from the GST mutant (85RRR87). (C) Cytoplasmic solubility of
recombinant GST-m3::ppGRN in presence (+) or absence ( ) of 2-HEDS with (+) or without ( ) DnaK co-expression in the recombinant E.coli culture.
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Figure 8. Amino acid sequence of putative DnaK-binding motif derived from
FTN-H,whichwascommonlycontainedinthesequenceofbothFTN-Lmutant
(77IFL79) and GST3(83GRIFLQD89)::ppGRN.
3758 Nucleic Acids Research, 2005, Vol. 33, No. 12formed spherical nanoparticles with diameters of 10–15 nm,
i.e. non-covalently cross-linked supra-molecules by self-
assembly. The particle size seems to be quite uniform for
each fusion protein. Considering that all the heterologous pro-
teins (EGF, IL-2, ppGRN, GAD512–585 and mpINS) were
aggregated into inclusion bodies when directly expressed in
E.coli, the results imply that the supra-molecule formation in
the shape of a spherical shell may provide signiﬁcant advan-
tage(s) in preventing protein aggregation. It seems that upon
supra-molecule formation, there must be a limitation in the
increase of the supra-molecule size due to the assembly prop-
erties of FTN-H. Therefore, self-assembled supra-molecules
were produced with a constant size of 10–15 nm, thereby
avoiding the undesirable formation of insoluble macro-
aggregates of heterologous proteins.
Immunoblotting analysis (western blot) following SDS–
PAGE analysis of the puriﬁed FTN-H::ppGRN showed an
apparent immunoreactive band (Figure 10B). When western
blot was carried out after native PAGE, however, no immun-
oreactive bands were visualized (Figure 10C), which clearly
indicates that a part of ppGRN, recognized by anti-ppGRN
monoclonal Ab, was localized inside the supra-molecules.
Thus, another plausible advantage of the self-assembled
supra-molecule is its prevention of protein aggregation by
non-speciﬁc hydrophobic interaction through the localization
of critical hydrophobic patches of the target protein inside the
supra-molecule.
DISCUSSION
As newly translated polypeptides emerge from the ribosome,
they face a formidable task in the crowded environment of the
cell: folding into their correct structure for proper functioning.
Molecular chaperones are essential for the correct folding of
a signiﬁcant fraction of cellular proteins under both physio-
logical and stress conditions (24), acting in a complex network
as a main defense against protein aggregation. Some chaper-
ones exhibit a holding activity, preventing polypeptides from
aggregation (25–27). Others show a complementary folding
role to assist in refolding and solubilization from aggregates
(28,29). Chaperones also minimize aggregation by mediating
the degradation of proteins that cannot be properly folded (30).
The speciﬁc contribution of particular chaperones to this
multifunctional folding network has only been partially iden-
tiﬁed. The Hsp70 chaperone DnaK serves as a central element
of the chaperone network, assisting in de novo protein folding,
protein translocation, oligomer dissociation and prevention
of stress-induced protein aggregation (31–33). DnaK mediates
protein folding through ATP-dependent interaction with
short linear peptide segments that are exposed on unfolded
proteins (34).
The heterologous expression of various human proteins
(EGF, IL-2, ppGRN, GAD512–585, ADI132–410 and mp-INS)
was attempted through the fusion of the target protein to
the C-terminus of FTN-H, all of which were produced as
inclusion bodies when directly expressed in E.coli. As a result,
the intracellular solubility of recombinant fusion proteins
(FTN-H::EGF, FTN-H::IL-2, FTN-H::ppGRN, FTN-
H::GAD512–585, FTN-H::ADI132–410 and FTN-H::mp-INS)
was signiﬁcantly enhanced (Figure 1). As explained above,
DnaK plays a central role in the initial folding of the nascent
polypeptide chain, and thus it seems reasonable to assume that
FTN-H has a signiﬁcant interaction with DnaK and contains
speciﬁc motif(s) that DnaK efﬁciently recognizes and binds to.
The results shown in Figures 3 and 9 strongly suggest that this
assumption is not irrational. Recently, Vandenbroeck et al.
(17) identiﬁed conserved DnaK-binding sites in the N- and
C-terminal halves of helix B and C of diverse 4-helix-bundle
proteins, respectively, that belong to the superfamily of inter-
feron-g/interleukin-10-related cytokines. In this study, we also
attempted to identify the speciﬁc amino acid residues of FTN-
H, if any, with a high afﬁnity to DnaK. Through systematic
investigation using site-directed mutagenesis, the oxidative
and forced protein aggregation technique and the DnaK co-
expression vector system (Figure 4), several putative binding
motifs were selected. It has been ﬁnally conﬁrmed through an
in vitro binding assay that DnaK recognizes an extended pep-
tide strand composed of a hydrophobic core of three residues
(Ile, Phe and Leu) and two ﬂanking regions enriched in polar
residues (Gly, Arg, Gln and Arg), such as the sequence
GRIFLQD (Figure 8), which seems similar to the ﬁndings
of Rudiger et al. (35). They reported that the DnaK-binding
motif consists of a hydrophobic core of four or ﬁve residues
enriched particularly not only in Leu, but also in Ile, Val, Phe
and Tyr and two ﬂanking regions enriched in basic residues.
Although recombinant FTN-L was all aggregated into inclu-
sion bodies in E.coli cytoplasm, the cytoplasmic solubility
of the recombinant FTN-L mutant containing the putative
DnaK-binding motif (GRIFLQD) was signiﬁcantly increased
(Figure 6B). The efﬁcacy of the binding motif was also val-
idated using a GST mutant (GST-m3) containing the same
motif sequence, i.e. the fusion protein GST-m3::ppGRN
was expressed as a cytoplasmic soluble protein. The sequence
1 2
Q L D F I R G
(A)
(B)
Q F D L A R G
Peptide A
Peptide B
FTN-L
FTN-L mutant
FTN-H
Ponceu S staining
Western blot
Figure 9. (A) Result of in vitro assay (Materials and Methods) to find binding
affinity between DnaK and synthetic peptides (A and B). Lane 1, result of
Ponceau S staining of immobilized peptides A and B prior to DnaK binding;
lane 2, result of immunoblotting using anti-DnaK monoclonal Ab). (B) Result
of in vitro assay (Materials and Methods) to find binding affinity between
DnaK and recombinant proteins (FTN-H, FTN-L and FTN-L mutant).
Nucleic Acids Research, 2005, Vol. 33, No. 12 3759GRIFLQD of FTN-H is located in the long loop between the
second and the third helix of the FTN-H, and the tertiary
structure of the FTN-H shows that the ﬂexible long loop con-
taining the binding motif is localized in the protein exterior. It
is therefore likely that association and dissociation of DnaK at
the binding motif would be quite efﬁcient at the early stage of
protein folding.
Similar to native human ferritin that is heteropolymer
(with the shape of a spherical shell) of 24 subunits of two
types, heavy chain and light chain, all the recombinant
proteins, including FTN-H, FTN-H::EGF, FTN-H::IL-2,
FTN-H::ppGRN, FTN-H::GAD512–585, FTN-H::ADI132–410
and FTN-H::mp-INS, have formed stable homopolymers
(i.e. supra-molecules) by non-covalent self-association. This
was conﬁrmed by the TEM images showing nanometer-scale
spherical particles of the recombinant proteins (Figure 10A).
Recently, Louzada et al. (36) proposed the mechanism of a
quaternary structure (dimer) formation in the folding pathway
of glutathione reductase (GR). They proposed that the assem-
bly of the native GR dimer proceed via the initial formation of
molten-globule monomers that dimerize to form a partially
folded, expanded dimer. Structural rearrangements then take
place at the dimer interface, leading to a ﬁnal, compact dimer
structure. Based on this proposed mechanism, it is presumed
that the intermolecular association of ferritin (or ferritin-
fusion) monomers to form homopolymeric supra-molecules
happens at the level of the partially folded (molten-globule)
intermediate, and not at the level of the completely folded and
(A)
(B) (C)
Figure 10. (A) TEM images of recombinant proteins (FTN-H, FTN-H::EGF, FTN-H::ADI132–410, FTN-H::IL-2, FTN-H::ppGRN, FTN-H::FTN-L,
FTN-H::GAD512–585, FTN-H::ADI132–410 and FTN-H::mpINS) purifiedafter expressed in E.coli cytoplasm. (B) Result of western blot analysis followingreducing
SDS–PAGE of purified FTN-H::ppGRN. (C) Result of western blot analysis following native PAGE of purified FTN-H::ppGRN.
3760 Nucleic Acids Research, 2005, Vol. 33, No. 12thermodynamically optimal polypeptide chain. Protein
aggregation, i.e. the off-pathway aggregation step, often ini-
tiates from partially folded intermediates upon intracellular
chain folding and association (37). Within cells, nascent
chains form sequentially on the ribosome, partially fold,
and sometimes fail to reach their native state because of the
intervention of various factors in a heterologous environment,
including non-speciﬁc hydrophobic interactions with the intra-
cellular cytoplasmic proteins (38), which sometimes cause the
formation of large and insoluble protein aggregates, i.e. inclu-
sion bodies. Supposing that as assumed earlier, the supra-
molecules of FTN-H or its fusion mutants are formed through
the self-association of partially folded intermediates, they may
have a distinct advantage in preventing the formation of insol-
uble protein aggregates; i.e. upon supra-molecule formation,
the supra-molecule size would be limited by the assembly
properties of FTN-H, and therefore, self-assembled supra-
molecules with constant sizes (10–15 nm) could be produced,
thereby avoiding the undesirable formation of insoluble
macro-aggregates of recombinant proteins (Figure 11).
As shown in Figure 11, a part of a target protein can be
localized within the spherical shell of the supra-molecule upon
the intermolecular association of a partially folded ferritin
monomer, and thus, a protective environment against undesir-
able protein aggregation can be created. Evidently, from
the results of the native PAGE and western blot analysis
for FTN-H::ppGRN (Figure 10B and C), an anti-ppGRN
mAb-speciﬁc epitope was shown to be localized inside the
supra-molecule. Hydrophobic patches of ppGRN may be
hidden together inside, which, otherwise, may be involved
in a non-speciﬁc hydrophobic interaction with the adjacent
polypeptide chains, leading to protein aggregation.
In conclusion, this study proposes the dual function of
FTN-H used for the fusion expression of heterologous pro-
teins: (i) high-afﬁnity interaction and association with DnaK
and (ii) formation of self-assembled supra-molecules with
limited and constant sizes, thereby preventing the undesirable
formation of insoluble macro-aggregates of heterologous pro-
teins and possibly creating a protective environment against
protein aggregation. Similarly, Hidaka et al. (18) found that
the propeptide of guanylyl cyclase activating peptide II
(GCAP-II), an endogenous ligand of guanylyl cyclase C,
has a dual function in the proper folding of the mature peptide.
Thus, the N-terminus propeptide of pro-GCAP-II is critical
not only for disulﬁde-coupled folding but also for the net
stabilization (or dimerization) of pro-GCAP-II. The ferritin
supra-molecular structure at the nanometer scale (or spherical
protein nanoparticles) can contribute to the enhancement of
the stability of synthesized recombinant proteins and can also
be used as a potent 3D probe structure for an ultra-sensitive
protein chip if a special expression system is designed so that
the captured probe peptide can be properly displayed at the
surface of the ferritin nanoparticles.
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